Mouse Mammary Cancer Models - Mechanisms and Markers

2001 ◽  
Author(s):  
Lawrence A. Donehower
Keyword(s):  
Mammary Cancer ◽  
Cancer Models

Antitumour activity of coumarin in prostate and mammary cancer models

1994 ◽  
Vol 120 (S1) ◽  
pp. S14-S16 ◽  
Author(s):  
E. von Angerer ◽  
M. Kager ◽  
A. Maucher
Keyword(s):  
Mammary Cancer ◽  
Antitumour Activity ◽  
Cancer Models

Comparing Genetically Engineered Mouse Mammary Cancer Models with Human Breast Cancer by Expression Profiling1

2007 ◽  
Vol 28 (1) ◽  
pp. 39-51 ◽  
Author(s):  
Alexander N. Shoushtari ◽  
Aleksandra M. Michalowska ◽  
Jeffrey E. Green
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Mammary Cancer ◽  
Genetically Engineered ◽  
Human Breast ◽  
Cancer Models

scholarly journals Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models

2018 ◽  
Author(s):  
Ronald Lubet ◽  
Vernon Steele ◽  
M. Juliana ◽  
Ann Bode ◽  
Fariba Moeinpour ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Egfr Inhibitors ◽  
Akt Inhibitor ◽  
Cancer Models

scholarly journals Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Collin Homer-Bouthiette ◽  
Yang Zhao ◽  
Lauren B. Shunkwiler ◽  
Benjamine Van Peel ◽  
Elizabeth Garrett-Mayer ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Gene Desert ◽  
Cancer Models ◽  
Anti Cancer

scholarly journals Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

Oncotarget ◽  
2020 ◽  
Vol 11 (32) ◽  
pp. 3048-3060
Author(s):  
Leandro E. Mainetti ◽  
María José Rico ◽  
Cintia Daniela Kaufman ◽  
Monica Carolina Grillo ◽  
Julian Guercetti ◽  
...  
Keyword(s):  
Therapeutic Effect ◽  
Mammary Cancer ◽  
Triple Negative ◽  
Cancer Models ◽  
Metronomic Cyclophosphamide
Sign in / Sign up

Export Citation Format

Share Document